Medical Thawing System Market Size to Hit US$ 301.5 Million in 2028 | Grow CAGR by 7.6%

IMARC Group, a leading market research company, has released a report titled "Medical Thawing System Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028". According to the report, The global medical thawing system market size reached US$ 191.0 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 301.5 Million by 2028, exhibiting a growth rate (CAGR) of 7.6% during 2023-2028.

A medical thawing system is essential equipment used in healthcare facilities to thaw frozen biological materials safely and efficiently, such as blood products, plasma, and tissues, while maintaining their integrity and viability. It employs controlled and gradual thawing processes to prevent damage to sensitive biological substances. It typically uses water baths, dry heat, or microwave technology, depending on the specific requirements of the materials being thawed. Additionally, it enhances patient care by preserving the effectiveness of critical medical materials, making them an essential investment for hospitals, blood banks, and research laboratories. As a result, medical thawing systems are employed in various medical applications, including transfusion medicine, organ transplantation, and laboratory research.

Request Your Sample Report Now: https://www.imarcgroup.com/medical-thawing-system-market/requestsample

Medical Thawing System Market Trends and Drivers:

The medical thawing system market is primarily driven by the increasing demand for cryopreservation. In addition, it is an essential technique in modern medicine, allowing for the long-term storage of various biological materials such as stem cells, tissues, and organs due to the need for reliable and efficient thawing systems, thus influencing market growth. Moreover, the ongoing technological advancements and incorporation of numerous features such as automation, precise temperature control, and user-friendly interfaces into medical thawing systems make them more appealing to healthcare facilities, thus representing another major growth-inducing factor. Along with this, several advancements in medical research, particularly in areas such as regenerative medicine and cellular therapy, need researchers to rely on frozen samples for their studies to maintain sample integrity and viability, thus propelling market growth. Furthermore, the increasing demand for medical thawing systems in the successful transplantation of organs and tissues due to the rising number of organ transplants is creating a positive market outlook.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

Manual
Automated

Breakup by Sample Type:

Blood
Plasma
Stem Cells
Whole Blood
Platelets
Embryo
Ovum
Semen

Breakup by End User:

Blood Banks
Hospitals
Tissue Banks
Pharmaceutical and Biotech Companies
Others

Market Breakup by Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

Competitive Landscape with Key Player:

Barkey GmbH & Co. KG
Biolife Solutions Inc.
Boekel Scientific
Cardinal Health Inc.
General Electric Company
Helmer Scientific Inc.
Hospicare Systems
labcold Limited
MMS Medical and Laboratory Supplies
Sarstedt AG & Co. KG
Sartorius AG
Terumo Penpol Private Limited (Terumo Corporation) and Thermo Fisher Scientific Inc.

Explore full report with table of contents: https://www.imarcgroup.com/medical-thawing-system-market

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Contact US

IMARC Group

Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.